NIH-funded research R01 grant

How microtubules help inner-ear hair cells develop and prevent deafness

Official title: Microtubule-Mediated Mechanisms Underlying Hair Cell Development and Deafness

Funded at University of Virginia · NIH-11390842 · Data updated 2026-11-12

Researchers are looking at how a gene called Cep85l helps inner-ear hair cells build the tiny bundles needed for hearing, which could explain some inherited hearing loss.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startMarch 1, 2014
Project endMarch 31, 2031
Funding year2026
Award (this year)$588,699
NIH project number2R01DC013773-11
Project IDNIH-11390842 on NIH RePORTER

Who could benefit from this research

Could help

People with unexplained sensorineural hearing loss, a family history of genetic deafness, or suspected mutations in CEP85L would be most relevant to this work.

Less likely to help

Those with conductive hearing loss from middle-ear problems or hearing loss solely due to loud-noise or age-related degeneration may not directly benefit from findings about hair-bundle morphogenesis.

What this research studies

The team studies the tiny hair cells in the cochlea that turn sound into nerve signals and how their internal skeletons (microtubules and actin) shape the stereocilia bundles. They use genetic tools such as CRISPR and Cep85l knockout mice along with high-resolution cell imaging to compare normal and mutant hair cells. By linking cellular structure changes to hearing loss, they aim to explain how mutations cause deafness and identify points that could be targeted by future therapies. The work connects a newly discovered deafness gene to the physical building of hair bundles that are essential for hearing.

Why it matters

Potential benefit: If successful, this could point to new genetic tests, guide early diagnosis, and identify targets for treatments to prevent or reduce certain kinds of inherited hearing loss.

How similar studies have gone: Prior mouse and cell studies linking other genes to hair-bundle defects have successfully explained forms of inherited deafness and helped genetic diagnosis, while work on Cep85l is a newer, specific direction.

Where this research is happening

  • University of Virginia
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Lu, Xiaowei — University of Virginia
  • Study coordinator: Lu, Xiaowei

Related research

Other NIH-funded projects on the same topics.

  • Gene therapy approach to Usher syndrome type 1F using compact PCDH15 in the inner ear

    A researcher team is developing a compact gene therapy using specially designed PCDH15 pieces delivered by AAV to the inner ear to help people with Usher syndrome type 1F.

    NIH research Massachusetts Eye and Ear Infirmary · Boston, United States · NIH-11370142

  • New genes for early-onset hearing loss and precision medicine

    Researchers are trying to identify genetic causes of hearing loss present at birth or in early childhood to enable earlier, DNA-based diagnoses and future gene-based therapies.

    NIH research University of Miami School of Medicine · Coral Gables, United States · NIH-11366340

  • Optimizing how CI users hear in busy real-world environments

    This grant studies how to improve speech understanding and spatial hearing for people using cochlear implants, especially those with implants in both ears or with single-sided deafness.

    NIH research Univ of Maryland, College Park · College Park, United States · NIH-11336385

  • Improving genetic testing for hearing loss

    This project works to make genetic test results clearer and more useful for people with inherited hearing loss.

    NIH research University of Iowa · Iowa City, United States · NIH-11287856

  • How Usher-1 proteins in inner-ear hair cells affect hearing

    This project looks at how key Usher-1 proteins help tiny hair cells in the inner ear work and how problems in these proteins lead to inherited hearing and vision loss for people with Usher syndrome.

    NIH research West Virginia University · Morgantown, United States · NIH-11233313

  • CRISPR-based exon-skipping to treat Usher syndrome deafness

    A gene-editing approach using CRISPR techniques to fix faulty exon regions in Usher syndrome patients to protect hearing and balance functions.

    NIH research University of Miami School of Medicine · Coral Gables, United States · NIH-11125786

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.